BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8682007)

  • 1. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study Investigators.
    Madjlessi-Simon T; Fillette F; Mary-Krause M; Lechat P; Jaillon P
    Eur Heart J; 1995 Dec; 16(12):1780-8. PubMed ID: 8682007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine reduces myocardial ischaemia during exercise without compromising left ventricular function in patients with silent ischaemia: a randomised, double-blind, placebo-controlled study.
    Bech J; Madsen JK; Kelbaek H
    Eur J Heart Fail; 1999 Dec; 1(4):395-400. PubMed ID: 10937953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).
    Deanfield JE; Detry JM; Lichtlen PR; Magnani B; Sellier P; Thaulow E
    J Am Coll Cardiol; 1994 Nov; 24(6):1460-7. PubMed ID: 7930276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
    Pehrsson SK; Ringqvist I; Ekdahl S; Karlson BW; Ulvenstam G; Persson S
    Clin Cardiol; 2000 Oct; 23(10):763-70. PubMed ID: 11061055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris.
    Klein G; Pfafferott C; Beil S; Gehring J; Niemelä M; Kendall MJ
    J Clin Pharm Ther; 1997; 22(5-6):371-8. PubMed ID: 19160722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine in patients with stable angina pectoris treated with beta-blockers. Double-blind comparison with placebo.
    Rossinen J; Partanen J; Nieminen MS
    Scand Cardiovasc J; 1998; 32(1):41-8. PubMed ID: 9536505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pointers from recent multicentre trials using ambulatory monitoring--placing placebo in perspective.
    Mulcahy D
    Eur Heart J; 1995 Dec; 16(12):1754-6. PubMed ID: 8682000
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and additional anti-ischaemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and long-term therapy of stable angina pectoris in patients pre-treated with a beta-blocker.
    Lehmann G; Reiniger G; Beyerle A; Rudolph W
    Eur Heart J; 1993 Nov; 14(11):1531-5. PubMed ID: 7905413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
    Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
    Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
    Knight CJ; Fox KM
    Am J Cardiol; 1998 Jan; 81(2):133-6. PubMed ID: 9591893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
    Erne P; Schoenenberger AW; Zuber M; Burckhardt D; Kiowski W; Dubach P; Resink T; Pfisterer M
    Eur Heart J; 2007 Sep; 28(17):2110-7. PubMed ID: 17644512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis significantly reduces transient myocardial ischaemia following first acute myocardial infarction.
    Mickley H; Pless P; Nielsen JR; Berning J; Møller M
    Eur Heart J; 1992 Apr; 13(4):484-90. PubMed ID: 1600986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine and the total ischemic burden: circadian anti-ischemia program in Europe (CAPE) trial-methodology, safety and toleration. The Steering Committee members and all of the investigators.
    Detry JM
    Cardiology; 1994; 85 Suppl 2():24-30. PubMed ID: 7736484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
    Davies RF; Habibi H; Klinke WP; Dessain P; Nadeau C; Phaneuf DC; Lepage S; Raman S; Herbert M; Foris K
    J Am Coll Cardiol; 1995 Mar; 25(3):619-25. PubMed ID: 7860905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
    Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
    J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
    Fox KM; Mulcahy D; Findlay I; Ford I; Dargie HJ
    Eur Heart J; 1996 Jan; 17(1):96-103. PubMed ID: 8682138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.